Activity of vorinostat (SAHA), cladribine (2-CdA), and rituximab in previously untreated mantle cell lymphoma: A phase I/II study.
S. E. F. Spurgeon
No relevant relationships to disclose
A. I. Chen
No relevant relationships to disclose
B. Ratterree
No relevant relationships to disclose
C. Okada
Honoraria - Merck
G. Palmbach
No relevant relationships to disclose
K. Diaz
No relevant relationships to disclose
N. Subbiah
No relevant relationships to disclose
C. Capper
No relevant relationships to disclose
E. E. Epner
Honoraria - Merck